Organ damage in zymosan-induced Multiple Organ Dysfunction Syndrome in mice is not mediated by inducible nitric oxide synthase

Critical Care Medicine

Volumn 30, Issue 7, 2002, Pages 1553-1559

  Volman, Thomas J H ^a   Goris, R Jan A ^a   Van Der Jagt, Michel ^a   Van De Loo, Fons A J ^a   Hendriks, Thijs ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Inflammation; Knockout mice; Multiple organ failure; Nitric oxide; Nitric oxide synthase antagonists and inhibitors; Zymosan

Indexed keywords

AMINOGUANIDINE; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; UNCLASSIFIED DRUG; ZYMOSAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ANALYSIS; HYPOTHERMIA; IMMUNOHISTOCHEMISTRY; KNOCKOUT GENE; LABORATORY; LIVER WEIGHT; LUNG WEIGHT; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SCORING SYSTEM; SPLEEN WEIGHT; SURVIVAL RATE; WEIGHT REDUCTION;

EID: 0036310110     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200207000-00026     Document Type: Article

References (39)

1. MOF/MODS, SIRS: An update
2. Multiple organ failure, multiple organ dysfunction syndrome, and the systemic inflammatory response syndrome - Where do we stand?
3. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): Are we winning the battle?
4. Bacterial translocation in multiple organ failure: Cause or epiphenomenon still unproven
5. Systemic inflammatory response syndrome
6. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation
7. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction
8. Multiple-organ failure. Generalized autodestructive inflammation?
9. The inflammatory basis of trauma/shock-associated multiple organ failure
10. Multiple-organ failure and sepsis without bacteria. An experimental model
11. Gradual development of organ damage in the murine zymosan-induced multiple organ dysfunction syndrome
12. The role of tumor necrosis factor in the development of multiple organ failure in a murine model
13. Interleukin-10 reduces morbidity and mortality in murine multiple organ dysfunction syndrome (MODS)
14. Development of a bacteria-independent model of the multiple organ failure syndrome
15. Inducible nitric oxide synthase: A little bit of good in all of us
16. Nitric oxide and intestinal inflammation
17. The role of nitric oxide in sepsis - An overview
18. Novel roles of nitric oxide in hemorrhagic shock
19. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase
20. The multiple organ dysfunction syndrome caused by endotoxin in the rat: Attenuation of liver dysfunction by inhibitors of nitric oxide synthase
21. Multiple organ failure following zymosan-induced peritonitis is mediated by nitric oxide
22. Increasing cytotoxic activity and production of reactive oxygen and nitrogen intermediates by peritoneal macrophages during the development of multiple organ dysfunction syndrome in mice
23. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase
24. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
25. Inflammatory cytokines in an experimental model for the multiple organ dysfunction syndrome
26. The potential role of nitric oxide in chronic inflammatory bowel disorders
27. Nitric oxide synthase and cyclooxygenases: Distribution, regulation, and intervention in arthritis
28. The role of nitric oxide in experimental glomerulonephritis
29. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
30. Aminoguanidine selectively inhibits inducible nitric oxide synthase
31. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase
32. Amino-guanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice
33. Attenuation of renal ischemia-reperfusion injury in inducible nitric oxide synthase knockout mice
34. Increased microvascular reactivity and improved mortality in septic mice lacking inducible nitric oxide synthase
35. Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice
36. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation
37. Role of nitric oxide in a nonseptic shock model induced by zymosan in the rat
38. Role of poly(ADP-ribose)synthetase in inflammation
39. Superoxide dismutase and catalase in an experimental model of multiple organ failure